GTF2H2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.27259999707741E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.01270000455401E-08 |
Normal-vs-Stage2 |
1.14160000341812E-08 |
Normal-vs-Stage3 |
2.36480000026518E-08 |
Normal-vs-Stage4 |
3.22700000054965E-07 |
Stage1-vs-Stage2 |
2.143400E-01 |
Stage1-vs-Stage3 |
3.646400E-01 |
Stage1-vs-Stage4 |
9.349400E-01 |
Stage2-vs-Stage3 |
7.535200E-01 |
Stage2-vs-Stage4 |
3.112600E-01 |
Stage3-vs-Stage4 |
4.672200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.34390000134022E-08 |
Normal-vs-AfricanAmerican |
5.12699993571175E-10 |
Normal-vs-Asian |
3.110500E-02 |
Caucasian-vs-AfricanAmerican |
1.040490E-02 |
Caucasian-vs-Asian |
2.095400E-01 |
AfricanAmerican-vs-Asian |
1.059580E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.3263999948675E-08 |
Normal-vs-Female |
4.70330000501562E-08 |
Male-vs-Female |
8.644200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.02560000001273E-07 |
Normal-vs-Age(41-60Yrs) |
2.01459999793485E-08 |
Normal-vs-Age(61-80Yrs) |
6.99329999465093E-08 |
Normal-vs-Age(81-100Yrs) |
8.33829999491442E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.902400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.236400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.921400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.504200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.844200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.940800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.25090000024919E-07 |
Normal-vs-Grade 2 |
2.67929999964167E-07 |
Normal-vs-Grade 3 |
8.95090002117627E-09 |
Normal-vs-Grade 4 |
1.3667999954059E-08 |
Grade 1-vs-Grade 2 |
7.713600E-02 |
Grade 1-vs-Grade 3 |
5.433400E-01 |
Grade 1-vs-Grade 4 |
4.863400E-01 |
Grade 2-vs-Grade 3 |
7.266500E-02 |
Grade 2-vs-Grade 4 |
1.064210E-01 |
Grade 3-vs-Grade 4 |
9.516800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.40849999996639E-07 |
Normal-vs-ccB subtype |
1.44609999530587E-08 |
ccA subtype-vs-ccB subtype |
2.056800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.89789999563928E-08 |
Normal-vs-N1 |
4.18870000000737E-05 |
N0-vs-N1 |
8.071400E-01 |
|
|